Masimo Net Profit Margin 2010-2024 | MASI
Current and historical net profit margin for Masimo (MASI) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Masimo net profit margin for the three months ending September 30, 2024 was .
| Masimo Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $2.04B | $0.08B | 3.87% |
| 2024-06-30 | $2.02B | $0.08B | 3.97% |
| 2024-03-31 | $1.98B | $0.08B | 4.05% |
| 2023-12-31 | $2.05B | $0.08B | 4.00% |
| 2023-09-30 | $2.12B | $0.09B | 4.21% |
| 2023-06-30 | $2.19B | $0.12B | 5.31% |
| 2023-03-31 | $2.30B | $0.12B | 5.14% |
| 2022-12-31 | $2.04B | $0.14B | 7.08% |
| 2022-09-30 | $1.75B | $0.17B | 9.79% |
| 2022-06-30 | $1.50B | $0.19B | 12.70% |
| 2022-03-31 | $1.24B | $0.22B | 17.93% |
| 2021-12-31 | $1.24B | $0.23B | 18.48% |
| 2021-09-30 | $1.21B | $0.23B | 19.24% |
| 2021-06-30 | $1.18B | $0.22B | 18.95% |
| 2021-03-31 | $1.17B | $0.23B | 19.52% |
| 2020-12-31 | $1.14B | $0.24B | 20.98% |
| 2020-09-30 | $1.10B | $0.22B | 20.24% |
| 2020-06-30 | $1.05B | $0.22B | 21.18% |
| 2020-03-31 | $0.98B | $0.21B | 21.60% |
| 2019-12-31 | $0.94B | $0.20B | 20.87% |
| 2019-09-30 | $0.91B | $0.19B | 20.79% |
| 2019-06-30 | $0.90B | $0.20B | 22.10% |
| 2019-03-31 | $0.88B | $0.20B | 22.44% |
| 2018-12-31 | $0.86B | $0.19B | 22.58% |
| 2018-09-30 | $0.84B | $0.14B | 16.47% |
| 2018-06-30 | $0.83B | $0.12B | 14.29% |
| 2018-03-31 | $0.81B | $0.12B | 14.76% |
| 2017-12-31 | $0.79B | $0.13B | 15.82% |
| 2017-09-30 | $0.78B | $0.36B | 45.85% |
| 2017-06-30 | $0.76B | $0.35B | 46.31% |
| 2017-03-31 | $0.74B | $0.34B | 45.47% |
| 2016-12-31 | $0.71B | $0.31B | 43.76% |
| 2016-09-30 | $0.68B | $0.11B | 16.20% |
| 2016-06-30 | $0.66B | $0.10B | 15.21% |
| 2016-03-31 | $0.65B | $0.09B | 13.91% |
| 2015-12-31 | $0.63B | $0.08B | 13.15% |
| 2015-09-30 | $0.63B | $0.08B | 12.78% |
| 2015-06-30 | $0.62B | $0.08B | 12.32% |
| 2015-03-31 | $0.60B | $0.07B | 11.79% |
| 2014-12-31 | $0.59B | $0.07B | 12.44% |
| 2014-09-30 | $0.57B | $0.06B | 10.76% |
| 2014-06-30 | $0.55B | $0.06B | 11.19% |
| 2014-03-31 | $0.55B | $0.07B | 11.82% |
| 2013-12-31 | $0.55B | $0.06B | 10.62% |
| 2013-09-30 | $0.54B | $0.06B | 11.94% |
| 2013-06-30 | $0.52B | $0.06B | 11.83% |
| 2013-03-31 | $0.51B | $0.06B | 12.35% |
| 2012-12-31 | $0.49B | $0.06B | 12.78% |
| 2012-09-30 | $0.47B | $0.06B | 13.11% |
| 2012-06-30 | $0.46B | $0.06B | 13.76% |
| 2012-03-31 | $0.45B | $0.06B | 13.93% |
| 2011-12-31 | $0.44B | $0.06B | 14.58% |
| 2011-09-30 | $0.43B | $0.07B | 15.24% |
| 2011-06-30 | $0.43B | $0.07B | 15.58% |
| 2011-03-31 | $0.42B | $0.06B | 15.24% |
| 2010-12-31 | $0.41B | $0.07B | 17.98% |
| 2010-09-30 | $0.39B | $0.07B | 18.07% |
| 2010-06-30 | $0.38B | $0.07B | 17.94% |
| 2010-03-31 | $0.36B | $0.07B | 18.46% |
| 2009-12-31 | $0.35B | $0.05B | 15.19% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.102B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.634B | 24.11 |
| Intuitive Surgical (ISRG) | United States | $186.606B | 97.56 |
| Edwards Lifesciences (EW) | United States | $43.604B | 27.69 |
| Alcon (ALC) | Switzerland | $41.521B | 27.78 |
| IQVIA Holdings (IQV) | United States | $34.761B | 19.15 |
| IDEXX Laboratories (IDXX) | United States | $33.493B | 39.44 |
| DexCom (DXCM) | United States | $29.615B | 44.60 |
| Waters (WAT) | United States | $21.413B | 31.66 |
| STERIS (STE) | Ireland | $20.170B | 23.22 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.359B | 0.00 |
| Hologic (HOLX) | United States | $16.058B | 17.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.192B | 13.54 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 36.77 |
| Globus Medical (GMED) | United States | $11.158B | 28.25 |
| Penumbra (PEN) | United States | $9.346B | 91.55 |
| Teleflex (TFX) | United States | $8.118B | 12.95 |
| Glaukos (GKOS) | United States | $7.925B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.457B | 25.26 |
| PROCEPT BioRobotics (PRCT) | United States | $4.215B | 0.00 |
| Inari Medical (NARI) | United States | $3.185B | 0.00 |
| Veracyte (VCYT) | United States | $3.028B | 90.86 |
| Nihon Kohden (NHNKY) | Japan | $2.590B | 19.67 |
| LivaNova (LIVN) | United Kingdom | $2.579B | 14.89 |
| Tandem Diabetes Care (TNDM) | United States | $2.185B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.096B | 18.84 |
| TransMedics (TMDX) | United States | $2.031B | 64.39 |
| Integra LifeSciences Holdings (IART) | United States | $1.675B | 8.75 |
| RxSight (RXST) | United States | $1.539B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.255B | 0.00 |
| Artivion (AORT) | United States | $1.173B | 77.69 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Paragon 28 (FNA) | United States | $0.820B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.760B | 12.92 |
| Mesa Laboratories (MLAB) | United States | $0.714B | 16.83 |
| IRadimed (IRMD) | United States | $0.676B | 36.54 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.657B | 0.00 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.568B | 29.92 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.430B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.407B | 22.01 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.357B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.349B | 0.00 |
| NeuroPace (NPCE) | United States | $0.333B | 0.00 |
| CVRx (CVRX) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.198B | 0.00 |
| Accuray (ARAY) | United States | $0.180B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.171B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.170B | 0.00 |
| Nevro (NVRO) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.123B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.118B | 12.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.094B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| 908 Devices (MASS) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.058B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |